Clinical Trials Browser

Phase NA × Hepatitis B, Chronic × peginterferon alfa-2b × Clear all

NCT05671315 2023-05-25

A Prospective Study to Evaluate Peginterferon in Reducing the Incidence of HCC in CHB Patients

Phase NA Unknown

Gastrointestinal

Carcinoma, Hepatocellular, Hepatitis B, Chronic